Patient-specific factors modulate leukocyte response in dimethyl fumarate treated MS patients. Goldman MD, Dwyer L, Coleman R, Sohn MW, et al. PLoS One 2020;15:e0228617.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Goldman MD, Dwyer L, Coleman R, Sohn MW, et al. Patient-specific factors modulate leukocyte response in dimethyl fumarate treated MS patients. PLoS One 2020;15:e0228617.
PMID: 32045436